Molecular Devices Home
Careers  |  Contact Us  |  Search:   

  

2008 Drug Discovery Forum

April 5, 2008, St. Louis, Missouri

We'd like to thank to all who attended our annual Drug Discovery Users Forum in St. Louis this year and made it such a success.

And we extend very special thanks to all of our distinguished speakers who so generously shared their research. Some of their presentations have been made available in downloadable .pdf format (below). If you are interested in a presentation that is not available here, please contact the speaker directly.

If you missed this year's meeting, check back at www.moleculardevices.com/events for news of next year's Drug Discovery Users Forum, and all the rest of our special events and trade shows.

  • If you always do what you have always done, you will always get what you always got. Implementation of “Jellyfish” into the Lead Generation
    Gary Allenby, Ph.D., AstraZeneca R&D Charnwood, U.K.

  • Use of the CellKey™ System for Studying Dopamine D3 Receptor Function in CHO Cells
    Claire Howes, Psychiatry CEDD, GlaxoSmithKline

  • Validation of Flashing and Glowing Aequorin Mutants for GPCR Screening Using the FLIPR Tetra® System with Aequorin Option
    Matthew Hsu, Ph.D., Millipore

  • Characterization of a Panel of Kinase Inhibitors by In Vitro and Functional Cellular Assays
    Lisa Martel, Ph.D., MDS Pharma Services

  • Comparison of a Label-Free Technology with Conventional Fluorescent-Based Technologies for Pharmacological Profiling of GPCRs
    David Piwnica, Ph.D., CEREP

  • Evaluation of a Fluorescent Dye-Based Biogenic Amine Transporter Uptake Assay using Primary Neuronal Cell Cultures
    Lesley A. Radov, Ph.D., Principal Investigator, AstraZeneca Pharmaceuticals

  • BacMam Technology and FLIPR Tetra – A Versatile System for 7TM and IC
    Paru Rao, GlaxoSmithKline

  • Miniaturized Cyclic Nucleotide-Gated (CNG) Channel Assays to Discover Neuropeptide Y Receptor Modulators
    Sanjay Adrian Saldanha, Ph.D., The Scripps Research Institute

  • High Throughput Screening for Identification of GPCR Agonists Using the Transfluor Internalization Technology
    Veronica Soloveva, Ph.D., Wyeth

  • Implementation of a 1536-well HCS for Compound Profiling Using the ImageXpress Ultra Platform
    Erica Stec, Ph.D., Merck

  • 1536-Well UHTS Screening with the FLIPR Tetra
    Robert N. Swanson, Ph.D., Pharmacopeia

  • Application of IMAP Based Phosphodiesterase Assay in 1536-Well Plate Format
    Menghang Xia, Ph.D., NIH Chemical Genomcs Center

  • Validation of High Throughput Screening Assays Against Three Subtypes of Cav3 T-type Channels using Molecular and Pharmacologic Approaches
    Xinmin Simon Xie, M.D., Ph.D., SRI International